Claim Missing Document
Check
Articles

Found 7 Documents
Search

Evaluation Of Antipsicotic Treatment In Skizofrenia Patients At Sambang Lihum Mental Hospital Muhammad Faqih; Hendera Hendera; Dedi Hartanto
JCPS (Journal of Current Pharmaceutical Sciences) Vol 5 No 1 (2021): September 2021
Publisher : LPPM - Universitas Muhammadiyah Banjarmasin

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Schizophrenia is a very serious mental disorder, which manifests as a collection of symptoms, including impaired thought processes, mood disorders, perceptual disturbances, and behavioral disorders that can lead to disability and dependence. At Sambang Lihum Hospital, South Kalimantan, schizophrenia is always included in the top 10 most treated psychiatric diseases. The purpose of this study was to evaluate the use of antipsychotic drugs in schizophrenic patients and determine its relationship to the length of stay of schizophrenic patients at the Sambang Lihum Hospital, South Kalimantan for the period October – December 2020. This study was an observational study with a cross-sectional design. Data collection was carried out by tracing medical records at the Sambang Lihum Hospital, South Kalimantan for the period October - December 2020. The results of an evaluation study on the use of antipsychotics in people with schizophrenia showed that the right drug was 96.7%, the correct dose was 97.5%, and the frequency was correct. 61.2%. The relationship between rationality and length of stay analyzed using the Chi-square test with the Continuity correction method obtained a significance value of 0.283 (more than 0.05). The conclusion obtained from the use of antipsychotics in schizophrenic patients has not been rational because of the evaluation of accuracy that is not in accordance with the literature. Based on the results of the analysis using the Chi-square test, there is no significant relationship between rationality and length of stay for schizophrenia patients at the Sambang Lihum Regional Mental Hospital, South Kalimantan
KESESUAIAN PENYIMPANAN OBAT HIGH ALERT DI INSTALASI FARMASI RUMAH SAKIT X BANJARMASIN Ilahi, Fitrah Shafran; Rahmah; Yumassik, Abdul Mahmud; Nordin; Ainah, Nur; Istiqamah, Farida; Faqih, Muhammad
Jurnal Insan Farmasi Indonesia Vol 8 No 1 (2025): Jurnal Insan Farmasi Indonesia
Publisher : Sekolah Tinggi Ilmu Kesehatan ISFI Banjarmasin

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36387/jifi.v8i1.2521

Abstract

High Alert is a type of drug that needs to be taken seriously as it can often lead to fatal errors and also has a high potential to trigger Adverse Drug Reactions. These drugs are divided into three categories, namely High Risk drugs, High Concentrate Electrolytes, and Look Alike Sound Alike/ Drug Name Look and Sound Similar. The purpose of this study was to assess the suitability of High Alert drug storage at the Banjarmasin X Hospital Pharmacy Installation based on the standard operating procedure for High Alert drug storage. The research method used qualitative observational with a cross-sectional approach. The study sample included 158 items of High Alert drugs in the Pharmacy Warehouse, Outpatient Pharmacy Depot, and Inpatient Pharmacy Depot, taken using the Total Sampling technique and data collected prospectively using a checklist sheet. Then processed with Microsoft Excel based on standard operating procedures. The results showed that the suitability of High Alert drug storage in the Pharmacy Warehouse was 99% (61 items), Outpatient Pharmacy Depot was 100% (41 items), and Inpatient Pharmacy Depot was 98% (51 items). Overall, the average suitability of High Alert drug storage in the three depots is 99% suitable in drug storage.
HUBUNGAN KOMPLEKSITAS REGIMEN PENGOBATAN DENGAN KEPATUHAN PENGOBATAN PASIEN DIABETES MELITUS TIPE 2 DI POLI PENYAKIT DALAM RSUD SULTAN SURIANSYAH BANJARMASIN Faqih, Muhammad; Alfian, Riza; Yumassik, Abdul Mahmud; Ilahi, Fitrah Shafran; Nordin, Nordin
Jurnal Ilmiah Ibnu Sina (JIIS): Ilmu Farmasi dan Kesehatan Vol 10 No 2 (2025): Jurnal Ilmiah Ibnu Sina
Publisher : Sekolah Tinggi Ilmu Kesehatan ISFI Banjarmasin

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36387/jiis.v10i2.2810

Abstract

Diabetes Mellitus (DM) is a chronic disease that requires prevention and treatment to reduce the various consequences associated with poor glycemic control. Diabetes mellitus treatment aims to control blood sugar levels within normal limits, improve the patient's quality of life, and prevent complications. One factor contributing to non-adherence to treatment in diabetes mellitus patients is the complexity of the medication regimen. This study aimed to examine the level of medication regimen complexity, medication adherence, and the relationship between medication regimen complexity and medication adherence in type 2 diabetes mellitus patients at the Internal Medicine Clinic of Sultan Suriansyah Hospital, Banjarmasin. This study used a cross-sectional design. Data were collected from August to September 2024, with 155 samples used in this study. The sampling method used a consecutive sampling technique. Medication regimen complexity (MRCI) data were obtained from prescriptions, while medication adherence data were collected using the Adherence to Refill Medication Scale (ARMS) questionnaire. The results of this study showed that the complexity of the patient's regimen was dominated by medications with a moderate level of complexity (75%, 48.4%). The results showed that the medication adherence rate was 61% of patients (39.4%). The correlation test showed an insignificant relationship between the complexity of the medication regimen and medication adherence, with a p value > 0.05 (0.139). Based on the research results, it can be concluded that the complexity of the medication regimen is not the main factor causing non-compliance in diabetes mellitus patients.
EKSPLORASI HAMBATAN KEPATUHAN PENGOBATAN PASIEN DIABETES MELITUS DI PUSKESMAS: STUDI KUALITATIF Alfian, Riza; Fawwazi, Muhammad Hafizh Abiyyu Fathin; Faqih, Muhammad; Adikusuma, Wirawan
Jurnal Ilmiah Ibnu Sina (JIIS): Ilmu Farmasi dan Kesehatan Vol 10 No 2 (2025): Jurnal Ilmiah Ibnu Sina
Publisher : Sekolah Tinggi Ilmu Kesehatan ISFI Banjarmasin

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36387/jiis.v10i2.2789

Abstract

Medication adherence is a crucial factor in the successful management of diabetes mellitus, yet many studies show that adherence remains low and is shaped by multidimensional influences. This study aimed to explore barriers to medication adherence among patients with diabetes mellitus in primary health centers (Puskesmas) using the WHO five-domain adherence framework. A qualitative descriptive-exploratory design was applied. Data were collected through in-depth interviews with ten patients undergoing routine treatment at Puskesmas in Banjarmasin City, recruited through purposive sampling. Thematic analysis was performed guided by the WHO adherence model. Five major themes emerged. Social and economic factors included limited transportation costs, distance to the health center, and lack of family support. Health system and provider factors involved brief consultations, insufficient patient education, and long queues. Condition-related factors comprised the absence of immediate symptoms, fatigue from chronic illness, comorbidities, and psychological distress. Therapy-related factors included complex regimens, side effects, and discontinuation of therapy without consultation. Patient-related factors were characterized by forgetfulness, reliance on alternative medicine, fluctuating motivation, and feelings of boredom. These findings highlight that adherence barriers are multidimensional and result from the interaction of individual, social, and system-level determinants. Addressing adherence requires holistic and continuous interventions at the primary care level, with emphasis on patient education, family involvement, and strengthening the role of healthcare providers.
Antiepileptic Drug Prescribing Patterns and Seizure Control Among Outpatients with Epilepsy at a Public Hospital in Indonesia Faqih, Muhammad; Cholisoh, Zakky; Seftiyanti , Nirma; Nugraheni, Ambar Yunita; Azmi, Rizki Nur
JSFK (Jurnal Sains Farmasi & Klinis) Vol 12 No 2 (2025): J Sains Farm Klin 12(2), August 2025
Publisher : Fakultas Farmasi Universitas Andalas

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.25077/jsfk.12.2.156-166.2025

Abstract

Background: Epilepsy affects nearly 50 million people globally, including approximately 700,000–1.4 million in Indonesia, with 70,000 new cases reported annually. Objective: This study aimed to determine antiepileptic drug (AED) prescribing patterns and to examine their association with seizure control outcomes in patients with epilepsy. Methods: A descriptive cross-sectional analysis was conducted using 185 outpatient prescriptions. Data on patient demographics, seizure frequency, and AED regimens were collected. Patterns of monotherapy and polytherapy were analyzed descriptively, and seizure control was compared using chi-square analysis. Results: Of the patients evaluated, 48.6% were male and 51.4% female. Monotherapy was prescribed in 51.4% of patients, predominantly valproic acid (VPA) and phenytoin (PHT). Polytherapy was used in 48.6% of patients, with the most common combinations being VPA + carbamazepine (CBZ) and PHT + VPA. Seizure-free control within six months was achieved in 34.6% of patients. A significant association was found between therapy regimen and seizure control (p = 0.040), with poor control more frequent in polytherapy (73.3%) than monotherapy (57.9%). Patients on polytherapy had twice the risk of poor seizure control (OR = 2.00; 95% CI: 1.08–3.72). Conclusion: Valproic acid remains the most prescribed AED for monotherapy, while phenytoin–valproic acid combinations are frequent in polytherapy. Polytherapy was associated with poorer seizure control, highlighting the importance of individualized AED selection and rational drug utilization in epilepsy management
COST UTILITY ANALYSIS PADA PASIEN DIABETES MELLITUS TIPE 2: INTEGRASI GULA DARAH, KOMORBIDITAS, BIAYA DAN KUALITAS HIDUP DALAM PENGAMBILAN KEPUTUSAN KLINIS Ilahi, Fitrah Shafran; Nordin; Faqih, Muhammad; Yumassik, Abdul Mahmud; Mellyani H.S, Ananda
Jurnal Ilmiah Ibnu Sina (JIIS): Ilmu Farmasi dan Kesehatan Vol 10 No 2 (2025): Jurnal Ilmiah Ibnu Sina
Publisher : Sekolah Tinggi Ilmu Kesehatan ISFI Banjarmasin

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36387/jiis.v10i2.2796

Abstract

Type 2 Diabetes Mellitus (T2DM) is one of the most prevalent chronic diseases in Indonesia and imposes a significant burden on healthcare costs. This study aimed to perform a Cost Utility Analysis (CUA) among T2DM patients by integrating blood glucose levels, comorbidities, direct medical costs, and quality of life. The research applied a cross-sectional design with prospective data collection using a convenience sampling technique. Quality of life was measured using the EQ-5D-5L questionnaire, while blood glucose levels, comorbidities, and direct medical costs were obtained from hospital medical records. Data analysis included descriptive statistics, Chi-Square tests, Logistic Regression analysis, and calculation of the utility index. The results showed that 38% of patients had good quality of life and 62% had poor quality of life, with an average utility index score of 0.5175. Random blood glucose levels of ≥200 mg/dL were found in 56% of respondents, while 44% had levels <200 mg/dL. Comorbidities were present in 52% of patients, while 48% had none. The median direct medical cost was IDR 425,500, with 62% categorized as high-cost and 38% as low-cost. Bivariate analysis revealed significant relationships between comorbidities, blood glucose levels, and direct medical costs with quality of life (p < 0.05). However, multivariate analysis showed that only blood glucose levels remained significant (p = 0.006). In conclusion, the overall quality of life of T2DM patients was generally poor, and blood glucose control was identified as the most influential independent factor affecting quality of life.
Islamic Business Ethics: Practice of Buying and Selling Antibiotics Without a Doctor's Prescription Dinda Putri Faridti; Nadia Dwi Oktaviani; Siti Baroroh Zakiyatul Islah; Muhammad Faqih; Mia Kusumawardani Samiyo
Solo International Collaboration and Publication of Social Sciences and Humanities Vol. 1 No. 03 (2023): Solo International Collaboration and Publication of Social Sciences and Humani
Publisher : Walidem Institute and Publishing

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61455/sicopus.v1i03.78

Abstract

Ethical dilemmas are associated with business, and identifying these ethical dilemmas is a key aspect of Islamic marketing strategy. In terms of terminology, business ethics is also called the science of good or bad behaviour regarding values. In simple terms, business ethics is an economic science that is often forgotten by society. Related to the existence of resistance due to irrational use of drugs, one of them is caused by use that is not by the patient's clinical conditions which occurs due to the use of antibiotics without a doctor's prescription. This occurs because it is easy for people to obtain antibiotics without considering or getting recommendations from authorized health workers, especially doctors (Ihsan et al., 2016). The purpose of this article is to explain Islamic ethics in business based on Islamic principles in health services when purchasing antibiotics without a doctor's prescription at pharmacies. The search method for scientific articles used as literature in this review is through the scientific journal article websites ScienceDirect, Scholar, Harzing Publish or Perish using the keywords "Islamic philosophical ethics"; “Islamic business ethics”; "antibiotics without a doctor's prescription". The importance of Islamic business ethics in antibiotic buying and selling transactions for patient health in using antibiotics appropriately to prevent antibiotic resistance and encouraging understanding of pharmacies to comply with health laws.